The OA_005 and OA_008 Phase 2 trials were both successful for the 2mg/kg twice weekly dose.
I assume the unsuccessful trial MixedBag is referring to is “Part 1” of the “Phase 2/3” OA_002 trial (i.e. the 600 subject dose-ranging trial), which used a maximum dose of 1.5mg/kg twice weekly.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)